ArticleGastro hep advances2024

Anti-PD-1 Autoantibody Predicts Survival of Patients With Hepatocellular Carcinoma Receiving Atezolizumab/Bevacizumab.

Yuki Sasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.